Europe confirms its position as the main source of pharmaceuticals for export.

The chart clearly shows how the European pharmaceutical industry has established itself in the global market. It is no coincidence that eXinvest of Emirates conducts trade with the top five European countries by business volume:

Germany shipped $104 billion in pharmaceuticals in 2024.

Switzerland followed with $95 billion.

Ireland delivered $77 billion.

Belgium exported $52 billion.

Italy reached $47.8 billion.

Comparing the total from these countries with the rest of the world highlights how geographically concentrated the opportunities are.

Contrast with the rest of the world:

The United States exported $81.2 billion.

China shipped $10.5 billion.

India reached $19.8 billion.

With 200 registered and affiliated pharmaceutical brokers, organized in research teams by area, country, and continent, eXinvest of Emirates can quickly source any missing drug by cross-referencing packaging and regulatory characteristics.

Finchemo acquires stakes in mid-size “friendly” companies and notable startups to increase synergies locally. Through this strategy, we offer our clients the best system for sourcing products from both invested companies and historical suppliers worldwide.

Europe has built its leadership by being the first to develop production centers, aggressively protecting intellectual property, attracting major pharmaceutical companies through fiscal policies and talent.

The future of pharmaceutical trade will continue to pass through this region. Germany, Switzerland, and Ireland lead with scale and massive infrastructure.

www.exinvest.ae
www.finchemo.com